-
Terminally ill cancer patients who had end-of life discussions with their physician had better quality of life during their last week and their caregivers had an easier bereavement.
-
A new agent has been approved by the fda for the treatment of thrombocytopenia associated with chronic immune thrombocytopenia purpura (ITP).
-
Previously undiagnosed cancer is frequent in patients with an unprovoked VTE and is more often detected with an extensive cancer screening strategy than with a limited screening strategy.
-
Lubiprostone, the new drug for idiopathic constipation, improved PEG-based colonoscopy preparation.
-
Approximately 50% of b-cell function has been lost at the time of initial diagnosis of type 2 diabetes.
-
-
Ongoing safety review of tiotropium; raloxifene reduces the risk of endometrial cancer; one-day treatment with famciclovir may be as effective as 3-day treatment with valacyclovir; new Clinical Practice Guideline from the American College of Physicians regarding pharmacologic treatment for low bone density and osteoporosis; FDA Actions.
-
-
Moll and colleagues from Amsterdam performed a subgroup analysis within their randomized clinical trial of women with polycystic ovary syndrome comparing metformin plus clomiphene treatment with clomiphene alone.
-
Glinert and colleagues from Israel report the use of photodynamic therapy to successfully ablate single feto-placental implantations in rats.
